Example of Drug Testing and Analysis format

Sample paper formatted on SciSpace - SciSpace

This content is only for preview purposes. The original open access content can be found here.

Open Access

Drug Testing and Analysis — Template for authors

Publisher: Wiley

Your data will always be in your control. Learn more

Get started with a free account

— or sign up using email —

See how it works

Guideline source

Categories	Rank	Trend in last 3 yrs
Pharmaceutical Science	#31 of 166	down by 7 ranks
Analytical Chemistry	#25 of 122	down by 5 ranks
Spectroscopy	#16 of 74	down by 5 ranks
Environmental Chemistry	#33 of 122	down by 9 ranks

Journal quality:

High

Last 4 years overview: 690 Published Papers | 4148 Citations

Indexed in: Scopus

Last updated: 16/07/2020

Related journals

Insights

General info

Related Journals

Open Access

Recommended

Journal of Pharmaceutical Analysis

Elsevier

Quality:

High

CiteRatio: 8.3

SJR: 0.786

SNIP: 1.529

Open Access

Recommended

Analytica Chimica Acta

Elsevier

Quality:

High

CiteRatio: 9.3

SJR: 1.403

SNIP: 1.369

Open Access

Journal of Pharmaceutical and Biomedical Analysis

Elsevier

Quality:

High

CiteRatio: 5.9

SJR: 0.777

SNIP: 1.246

Open Access

Journal of Analysis and Testing

Springer

Quality:

Good

CiteRatio: 3.0

SJR: 0.406

SNIP: 0.549

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

2.903

4% from 2018

Impact factor for Drug Testing and Analysis from 2016 - 2019
Year	Value
2019	2.903
2018	2.799
2017	2.993
2016	3.469

Graph view

6.0

13% from 2019

CiteRatio for Drug Testing and Analysis from 2016 - 2020
Year	Value
2020	6.0
2019	5.3
2018	5.2
2017	6.1
2016	5.6

Graph view

Insights

Impact factor of this journal has increased by 4% in last year.
This journal’s impact factor is in the top 10 percentile category.

Insights

CiteRatio of this journal has increased by 13% in last years.
This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.065

19% from 2019

SJR for Drug Testing and Analysis from 2016 - 2020
Year	Value
2020	1.065
2019	0.898
2018	0.747
2017	0.884
2016	1.027

Graph view

1.136

7% from 2019

SNIP for Drug Testing and Analysis from 2016 - 2020
Year	Value
2020	1.136
2019	1.061
2018	0.997
2017	1.04
2016	0.928

Graph view

Insights

SJR of this journal has increased by 19% in last years.
This journal’s SJR is in the top 10 percentile category.

Insights

SNIP of this journal has increased by 7% in last years.
This journal’s SNIP is in the top 10 percentile category.

Drug Testing and Analysis

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Wiley

Drug Testing and Analysis

As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances. In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds). Rather than focus on the application of a single technique, Drug Testing and Analysis employs a unique multidisciplinary approach to the field of controversial compound determination. Papers discussing chromatography, mass spectrometry, immunological approaches, 1D/2D gel electrophoresis, to name just a few select methods, are welcomed where their application is related to any of the six key topics listed below. Features and Coverage The journal will focus on six key topics • Sports doping Illicit/recreational drugs use e.g. drug-testing methods by employersPharmaceuticals e.g. pharmacokinetics, metabolism studies, characterization and detection of new therapeutics, natural products, biosimilars and genericsToxico-pathology e.g. determining posthumous drug presenceForensics/homeland security e.g. determining the presence of controlled substances at a crime scene or use by perpetrators, analysis of compounds with potential use as biological or chemical warfare agentsEnvironment e.g. wastewater analysis, determination of pollutants/contaminants, etc. Read Less

Pharmaceutical Science

Spectroscopy

Analytical Chemistry

Environmental Chemistry

Pharmacology, Toxicology and Pharmaceutics

Last updated on	15 Jul 2020
ISSN	1942-7603
Impact Factor	High - 1.075
Open Access	Yes
Sherpa RoMEO Archiving Policy	Yellow
Plagiarism Check	Available via Turnitin
Endnote Style	Download Available
Bibliography Name	apa
Citation Type	Numbered [25]
Bibliography Example	Blonder GE, Tinkham M, Klapwijk TM. Transition from metallic to tunneling regimes in supercon- ducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys Rev B. 1982;25(7):4515_x0015_4532. Available from: 10.1103/PhysRevB.25.4515.

Top papers written in this journal

Journal Article • DOI: 10.1002/DTA.313 •

Cathinone derivatives: A review of their chemistry, pharmacology and toxicology

John P. Kelly¹ •

01 Jul 2011 - Drug Testing and Analysis

Abstract:

The purpose of this review is to evaluate what is currently known about the pharmacology of cathinone derivatives. Cathinone is the principal active constituent of khat responsible for the stimulant effects that have led khat to be known as a 'natural amphetamine'. Synthetic derivatives have been abused for their amphetamine-... The purpose of this review is to evaluate what is currently known about the pharmacology of cathinone derivatives. Cathinone is the principal active constituent of khat responsible for the stimulant effects that have led khat to be known as a 'natural amphetamine'. Synthetic derivatives have been abused for their amphetamine-like stimulant effects, most notably methylone, methcathinone (ephedrone), and 4-methlymethcathinone (mephedrone). To date, cathinone and methcathinone have been studied most, demonstrating amphetamine-like effects in a range of in vitro and in vivo investigations, albeit less potently than amphetamines. In humans, cathinone derivatives are usually administered orally, and in some cases by insufflation. Methcathinone has a longer history of abuse, being produced from readily available starting materials, and administered by injection. Mephedrone has become the best publicised cathinone derivative, amid considerable media and public concern about its legal status, its ready availability, and reports of serious toxicity and deaths following its use. As a consequence, there has been a clampdown on cathinone derivatives, dramatically changing their legal status in a number of countries. However, little objective evidence-based comparative experiments have been conducted to date between these compounds and their related amphetamines in order to make clear risk judgements. Such assessments have largely been predictive in nature, based on their structural similarity to amphetamines. It can be assumed that, despite their illegal status, cathinone-related compounds will continue to be prevalent drugs of abuse for the foreseeable future. read more

Topics:

Mephedrone (66%)66% related to the paper, Cathinone (65%)65% related to the paper, Methcathinone (60%)60% related to the paper,

300 Citations

Open access • Journal Article • DOI: 10.1002/DTA.155 •

Analyses of second-generation 'legal highs' in the UK: initial findings.

Simon D. Brandt¹, Harry Sumnall¹, •

01 Aug 2010 - Drug Testing and Analysis

Abstract:

In the UK, mephedrone and other so-called ‘legal high’ derivatives have recently been classified as Class B, Schedule I under the Misuse of Drugs Act 1971. Since then, alternative products have been advertised on a number of websites. In order to obtain an immediate snapshot of the situation, 24 products were purchased online... In the UK, mephedrone and other so-called ‘legal high’ derivatives have recently been classified as Class B, Schedule I under the Misuse of Drugs Act 1971. Since then, alternative products have been advertised on a number of websites. In order to obtain an immediate snapshot of the situation, 24 products were purchased online from 18 UK-based websites over a period of 6 weeks following the ban in April 2010. Qualitative analyses were carried out by gas chromatography ion trap mass spectrometry using electron- and chemical ionization modes, nuclear magnetic resonance spectroscopy, and comparison with reference standards. Overall, the purchased products consisted of single cathinones or cathinone mixtures including mephedrone, butylone, 4-methyl-N-ethylcathinone, flephedrone (4-fluoromethcathinone) and MDPV (3,4-methylenedioxypyrovalerone), respectively. Benzocaine, caffeine, lidocaine, and procaine were also detected. The emphasis was placed on ‘Energy 1’ (NRG1), a product advertised as a legal replacement for mephedrone-type derivatives usually claiming to contain naphyrone (naphthylpyrovalerone, O-2482). It was found that 70% of NRG-1 and NRG-2 products appeared to contain a mixture of cathinones banned in April 2010 and rebranded as ‘new’ legal highs, rather than legal chemicals such as naphyrone as claimed by the retailers. Only one out of 13 NRG-1 samples appeared to show analytical data consistent with naphyrone. These findings also suggest that both consumers and online sellers (unlike manufacturers and wholesalers) are, most likely unknowingly, confronted with the risk of criminalization and potential harm. Copyright c � 2010 John Wiley & Sons, Ltd. read more

Topics:

Naphyrone (63%)63% related to the paper, Flephedrone (54%)54% related to the paper, Mephedrone (52%)52% related to the paper

View PDF

265 Citations

Journal Article • DOI: 10.1002/DTA.1620 •

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.

Hamilton Morris¹, Jason Wallach² •

01 Jul 2014 - Drug Testing and Analysis

Abstract:

PCP or phencyclidine was discovered in 1956 and soon became a popular street drug. Dissociatives including PCP, ketamine, and dextromethorphan have been used non-medically for their mind-altering effects for over 60 years. Many of these compounds have also been used clinically and in legitimate research. At least 14 derivativ... PCP or phencyclidine was discovered in 1956 and soon became a popular street drug. Dissociatives including PCP, ketamine, and dextromethorphan have been used non-medically for their mind-altering effects for over 60 years. Many of these compounds have also been used clinically and in legitimate research. At least 14 derivatives of PCP were sold for non-medical and illict use from the late 1960s until the 1990s. With the advent of the Internet, the drug market underwent a dramatic evolution. While initially gray-market chemical vendors offering dextromethorphan and ketamine thrived, most recently the market has shifted to legal high and online-based research chemical vendors. Starting with the first dissociative research chemical, 4-MeO-PCP in 2008, the dissociative research chemical market has rapidly evolved and currently comprises at least 12 dissociatives, almost half of which were unknown in the scientific literature prior to their introduction. Several of these, including methoxetamine, have reached widespread use internationally. A historical account of non-medical use of over 30 dissociative compounds was compiled from a diverse collection of sources. The first complete portrait of this underground market is presented along with the relevant legal, technological, and scientific developments which have driven its evolution. read more

Topics:

Research chemical (52%)52% related to the paper, Poison control (51%)51% related to the paper

201 Citations

Journal Article • DOI: 10.1002/DTA.220 •

Adulterants in illicit drugs: a review of empirical evidence

Claire Cole¹, Lisa Jones¹, •

01 Feb 2011 - Drug Testing and Analysis

Abstract:

Widespread public perception is that illicit drugs contain substances that are a serious risk to health, even though adulterants are often not considered in clinical or forensic toxicology. This review attempts to present an evidence-based overview of adulterants in illicit drugs, and their associated toxicity. Adulterants ar... Widespread public perception is that illicit drugs contain substances that are a serious risk to health, even though adulterants are often not considered in clinical or forensic toxicology. This review attempts to present an evidence-based overview of adulterants in illicit drugs, and their associated toxicity. Adulterants are deliberately added to increase bulk, enhance or mimic a pharmacological effect, or to facilitate drug delivery. Those present unintentionally are as a result of poor manufacturing techniques. From the reports gathered, adulterants are predominantly substances which are readily available, commonly being caffeine, procaine, paracetamol, and sugars. These are likely to have minimal impact on users' health at low dosages. Other adulterants, particularly in injectable drugs, have the potential to cause serious health issues, but the quantities reported, such as strychnine in heroin, are not life-threatening. The most commonly identified bacterial contaminants identified are Bacillus and Clostridium species. When death or serious illness due to adulteration occurs, circulation of information is particularly vital, such as in the USA regarding heroin and cocaine adulterated with fentanyl, and in Scotland recently regarding anthrax contaminated heroin. The complex interactions of supply, demand, and control of illicit drugs have a tangible impact on their adulteration. Continuing vigilance and the circulation of information is, therefore, desirable as a public health issue. As part of that strategy, analyses performed for adulterants needs to be encouraged, which are considerably limited in number and scope at the moment. read more

185 Citations

Journal Article • DOI: 10.1002/DTA.1506 •

The adverse health effects of chronic cannabis use

Wayne Hall¹, Wayne Hall², •

01 Jan 2014 - Drug Testing and Analysis

Abstract:

This paper summarizes the most probable of the adverse health effects of regular cannabis use sustained over years, as indicated by epidemiological studies that have established an association between cannabis use and adverse outcomes; ruled out reverse causation; and controlled for plausible alternative explanations. We have... This paper summarizes the most probable of the adverse health effects of regular cannabis use sustained over years, as indicated by epidemiological studies that have established an association between cannabis use and adverse outcomes; ruled out reverse causation; and controlled for plausible alternative explanations. We have also focused on adverse outcomes for which there is good evidence of biological plausibility. The focus is on those adverse health effects of greatest potential public health significance – those that are most likely to occur and to affect a substantial proportion of regular cannabis users. These most probable adverse effects of regular use include a dependence syndrome, impaired respiratory function, cardiovascular disease, adverse effects on adolescent psychosocial development and mental health, and residual cognitive impairment. Copyright © 2013 John Wiley & Sons, Ltd. read more

Topics:

Adverse effect (53%)53% related to the paper, Cannabis (53%)53% related to the paper, Public health (51%)51% related to the paper

View PDF

184 Citations

Also popular among researchers

“

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds

Choose a template

Select a template from a library of 40,000+ templates

Import a MS-Word file or start fresh

It takes only few seconds to import

View and edit your final output

SciSpace will automatically format your output to meet journal guidelines

Submit directly or Download

Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

With SciSpace, you do not need a word template for Drug Testing and Analysis.

It automatically formats your research paper to Wiley formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

Easy support from all your favorite tools

Drug Testing and Analysis format uses apa citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Drug Testing and Analysis in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Drug Testing and Analysis guidelines and auto format it.

2. Do you follow the Drug Testing and Analysis guidelines?

Yes, the template is compliant with the Drug Testing and Analysis guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Drug Testing and Analysis?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Drug Testing and Analysis citation style.

4. Can I use the Drug Testing and Analysis templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Drug Testing and Analysis.

5. Can I use a manuscript in Drug Testing and Analysis that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Drug Testing and Analysis that you can download at the end.

6. How long does it usually take you to format my papers in Drug Testing and Analysis?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Drug Testing and Analysis.

7. Where can I find the template for the Drug Testing and Analysis?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Drug Testing and Analysis's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Drug Testing and Analysis's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Drug Testing and Analysis an online tool or is there a desktop version?

SciSpace's Drug Testing and Analysis is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Drug Testing and Analysis?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Drug Testing and Analysis?”

11. What is the output that I would get after using Drug Testing and Analysis?

After writing your paper autoformatting in Drug Testing and Analysis, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Drug Testing and Analysis's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Drug Testing and Analysis?

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Drug Testing and Analysis. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour	Archiving policy
Green	Can archive pre-print and post-print or publisher's version/PDF
Blue	Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow	Can archive pre-print (ie pre-refereeing)
White	Archiving not formally supported

FYI:

Pre-prints as being the version of the paper before peer review and
Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Drug Testing and Analysis?

The 5 most common citation types in order of usage for Drug Testing and Analysis are:.

S. No.	Citation Style Type
1.	Author Year
2.	Numbered
3.	Numbered (Superscripted)
4.	Author Year (Cited Pages)
5.	Footnote

15. How do I submit my article to the Drug Testing and Analysis?

16. Can I download Drug Testing and Analysis in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Drug Testing and Analysis Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Drug Testing and Analysis formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

“

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

”

Andreas Frutiger
Researcher & Ex MS Word user

Drug Testing and Analysis — Template for authors

Related Journals

Journal Performance & Insights

Impact Factor

CiteRatio

2.903

6.0

Insights

Insights

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

1.065

1.136

Insights

Insights

Drug Testing and Analysis

Drug Testing and Analysis

Top papers written in this journal

Abstract:

Topics:

Abstract:

Topics:

Abstract:

Topics:

Abstract:

Abstract:

Topics:

What to expect from SciSpace?

Speed and accuracy over MS Word

Plagiarism Reports via Turnitin

Freedom from formatting guidelines

Easy support from all your favorite tools

Frequently asked questions

Fast and reliable, built for complaince.

No word template required

Verifed journal formats

Trusted by academicians

Fast and reliable,
built for complaince.